Thymopoietin II Fragment (TP-1) (TP1)
Immune
Preclinical
Active fragment of thymopoietin that modulates T-cell differentiation and immune function.
Key Data
- Research Status
- Preclinical
- Half-Life
- Unknown
- Administration
- Subcutaneous injection
- Typical Dosage
- Research varies
Mechanism of Action
Induces T-cell differentiation markers and modulates immune cell function.
Reported Benefits
- T-cell maturation
- Immune modulation
- Lymphocyte function
All information is presented for Research Use Only (RUO). Not medical advice.